This page lists the SEC filings reported by Deep Track Capital, LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-04-26 | Deep Track Capital, LP | Korro Bio, Inc. | 714,285 | 7.7% | EDGAR |
| SC 13G | 2024-04-26 | Deep Track Capital, LP | INOVIO PHARMACEUTICALS, INC. | 2,593,822 | 10.0% | EDGAR |
| SC 13G/A | 2024-04-22 | Deep Track Capital, LP | Zura Bio Ltd | 6,216,327 | 9.3% | EDGAR |
| SC 13G | 2024-04-12 | Deep Track Capital, LP | Guardant Health, Inc. | 7,000,000 | 5.8% | EDGAR |
| SC 13G | 2024-04-05 | Deep Track Capital, LP | Avalo Therapeutics, Inc. | 114,775 | 10.0% | EDGAR |
| SC 13G | 2024-03-22 | Deep Track Capital, LP | CYBIN INC. | 58,139,535 | 7.6% | EDGAR |
| SC 13G | 2024-03-22 | Deep Track Capital, LP | Regulus Therapeutics Inc. | 6,888,424 | 10.0% | EDGAR |
| SC 13G | 2024-03-22 | Deep Track Capital, LP | Olema Pharmaceuticals, Inc. | 3,040,248 | 5.4% | EDGAR |
| SC 13G | 2024-03-15 | Deep Track Capital, LP | Mind Medicine (MindMed) Inc. | 6,666,667 | 9.5% | EDGAR |
| SC 13G | 2024-03-08 | Deep Track Capital, LP | Pyxis Oncology, Inc. | 4,184,100 | 7.9% | EDGAR |
| SC 13G | 2024-02-23 | Deep Track Capital, LP | enGene Holdings Inc. | 2,250,000 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Acumen Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | AGENUS INC | 31,697,539 | 8.3% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | ALBIREO PHARMA, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Allakos Inc. | 2,510,736 | 2.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Ambrx Biopharma, Inc. | 3,710,412 | 5.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | ANAPTYSBIO, INC | 2,036,990 | 7.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Apogee Therapeutics, Inc. | 2,323,456 | 6.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Astria Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Deep Track Capital, LP | Autolus Therapeutics plc | 11,869,297 | 6.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.